The Tennessee Department of Treasury bought a new position in stock, while Citigroup reaffirmed its 'outperform' rating and Leerink Partners set a $43.00 price objective.
1 report, 1 independent
Updated Jul 9
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The Tennessee Department of Treasury bought a new position in stock, while Citigroup reaffirmed its 'outperform' rating and Leerink Partners set a $43.00 price objective.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Tennessee Department of Treasury
Tennessee state department
Nothing else this week.
-
Sutro Biopharma
company
Nothing else this week.
-
Citigroup
American investment bank and financial services corporation
-
Leerink partners
U.S. investment bank
Related events
- Financial entities, including Legal & General Group Plc, bought new stakes in Magic Software Enterprises Ltd., which is based in the State of Wyoming.
- Needham & Company issued a buy rating, and Leerink Partners began coverage of Collegium Pharmaceutical, Inc. on September 23, 2026.
- Anixa Biosciences disclosed an insider purchase via SEC filing, coinciding with MarketBeat price target changes and a buy rating restatement from Citigroup.
- Leerink partners issued an 'outperform' rating on Teva stock, while an insider sold shares of the company.
- Scansource was listed on the Nasdaq stock exchange, and the Tennessee Department of Treasury increased its holdings in the company's stock.